Search
-
Q3 2019 pre announcement aide memoire
Media
https://www.gsk.com/media/5721/q3-2019-pre-announcement-aide-memoire.pdf
First published: 09 October 2019
-
Q2 2019 results transcript
Media
https://www.gsk.com/media/5672/q2-2019-results-transcript.pdf
First published: 25 July 2019
-
Q3 2020 results transcript
Media
https://www.gsk.com/media/6197/q3-2020-results-transcript.pdf
First published: 28 October 2020
-
Q3 2019 results transcript
Media
https://www.gsk.com/media/5746/q3-2019-results-transcript.pdf
First published: 31 October 2019
-
Q1 2019 results slides
Media
https://www.gsk.com/media/5556/q1-2019-results-slides.pdf
First published: 01 May 2019
-
Q2 2021 results slides
Media
https://www.gsk.com/media/7129/q2-2021-results-slides.pdf
First published: 28 July 2021
-
ViiV Healthcare announces positive Week 48 results in first study to evaluate treatment switch from TAF-containing regimen with three or more drugs to 2-drug regimen of dolutegravir/lamivudine for HIV-1 infection
Media
International AIDS Society Conference on HIV Science demonstrate non-inferior efficacy of Dovato▼ in virally suppressed adults with HIV
https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-positive-week-48-results-in-first-study-to-evaluate-treatment-switch-from-taf-containing-regimen/
First published: 24 July 2019
-
Jp Morgan Final 14 Jan 2020
Media
https://www.gsk.com/media/8105/jp-morgan-final-14-jan-2020.pdf
First published: 01 June 2022
-
Q2 2019 US dollar translation
Media
https://www.gsk.com/media/5661/q2-2019-us-dollar-translation.pdf
First published: 24 July 2019
-
Q3 2019 US dollar translation
Media
https://www.gsk.com/media/5738/q3-2019-us-dollar-translation.pdf
First published: 30 October 2019